查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1839059

细胞分离/细胞分离市场（按产品、技术、细胞类型、应用和最终用户）—全球预测 2025-2032

Cell Isolation/Cell Separation Market by Product, Technology, Cell Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，细胞分离/细胞分离市场将成长至 392.5 亿美元，复合年增长率为 14.88%。

主要市场统计数据
基准年2024年 129.3亿美元
预计2025年 148.4亿美元
预测年份：2032年 392.5亿美元
复合年增长率（%） 14.88%

核心细胞分离技术、不断变化的最终用户优先事项以及影响转化研究和临床流程的策略考虑的简要说明

细胞分离和离析技术支撑着从基础免疫学研究到先进细胞疗法製造等广泛的生命科学研究和临床应用。仪器和试剂的进步正在逐步降低精确单细胞和批量细胞处理的门槛，从而实现更可重复的工作流程并加速转化路径。随着学术团体、生物技术创新者和临床实验室日益寻求可扩展且易于自动化的解决方案，可用工具的种类也日益多样化，以满足对通量、纯度和活力的不同要求。

因此，相关人员不仅要评估技术的分析效能，还要评估其与资料流程、法规遵循框架和下游处理的整合程度。微射流、磁分离和高解析度流式细胞技术与云端数据分析的融合正在重塑团队的实验设计和流程扩展。本简介将重点介绍核心技术驱动因素、不断变化的最终用户需求以及在研究、临床和商业环境中为采购和开发选择提供参考的战略考量，从而构成以下章节的框架。

技术融合、自动化和数据支援的工作流程如何重新定义细胞分离并重塑供应商与最终用户之间的动态

技术融合和不断变化的应用需求共同改变了细胞​​分离的模式。最初的改进主要集中在透过改进试剂和提高灵敏度的流式细胞仪来提高细胞纯度和回收率。最近，自动化样品处理和计算分析的整合带来了最深刻的变化。

此外，更温和的分离方式的开发，例如奈米材料增强磁珠和旨在保留细胞表型的微流体平台，为干细胞和原代免疫群体等精细细胞类型开闢了新的可能性。因此，曾经需要专业知识的工作流程现在可供更广泛的最终用户使用。同时，竞争力量正推动供应商将耗材与服务模式和软体捆绑在一起，建立生态系统并加速采用，但也引发了对供应商锁定和资料互通性的担忧。这种转变促使实验室和主要企业重新评估其采购标准，重点关注营运连续性、数据完整性以及将分离细胞输出转化为下游检测和疗法的能力。

评估 2025 年美国关税调整如何改变整个电池分离生态系统的采购、供应链策略和製造商采购决策

美国近期宣布的2025年关税调整带来了新的变量，将影响细胞分离领域的筹资策略、供应链弹性和跨境合作。设备和专用试剂的进口关税上调将增加到岸成本，迫使实验室采购团队重新评估采购时机、供应商选择和库存策略。因此，各机构需要在短期成本压力与更换供应商或采用工作流程可能尚未完全检验的替代技术所带来的长期营运风险之间取得平衡。

除了影响价格外，关税还会影响供应商的行为和投资决策。一些製造商正在透过扩大生产区域、实现零件采购多元化或调整分销模式来应对关税的影响。这些调整可能会为依赖一致试剂批次或仪器零件相容性的客户带来过渡摩擦。由于关税分类变化而加剧的监管和海关延误，也延长了前置作业时间，并使即时库存方法变得复杂。为了因应这种环境，企业越来越重视多源采购策略，并与供应商建立密切合作，以确保供应的连续性，并在贸易政策变化的情况下保持实验的可重复性。

全面的细分主导洞察，将产品类型、实行技术、细胞类型和最终用户优先级联繫起来，为采购和开发决策提供讯息

要了解市场动态，需要明确多个细分维度以及每个类别对买家和开发者的实际意义。在耗材领域，抛弃式和试剂决定了每次运行的经济性和检测的一致性，而数据分析软体和维护服务则决定了生命週期价值和执行时间。同时，流式细胞技术、磁珠和微射流支援更高的解析度和精准的应用。流式细胞技术本身又分为分析型细胞仪和分选型细胞仪，磁珠技术因规模而异，从大珠到奈米珠，每种技术在结合动力学和细胞回收率方面都有各自的优缺点。

B 细胞、T 细胞、树突状细胞、干细胞和癌细胞对维持活力、纯度阈值和下游适用性都有不同的要求。同时，感染疾病和产前检测优先考虑速度、诊断灵敏度和监管可追溯性。最后，最终用户的细分凸显了其营运的多样性：学术研究机构优先考虑实验灵活性和成本效益；生物技术和製药公司重视扩充性和监管合规性；委外研发机构重视通量、可重复性和客户报告；医院和诊所需要临床级可靠性以及与患者照护途径的整合。这些细分视角共同构成了一幅细緻入微的需求图，创新者和负责人在评估技术和伙伴关係时必须考虑。

影响美洲、欧洲、中东和非洲地区以及亚太地区的招募速度、供应商策略和监管协调的区域动态和基础设施考量

每个地区的动态对技术采用、供应商策略和监管参与提出了不同的要求。在美洲，转化研究的投资和细胞疗法製造中心的成长，推动了对符合GMP标准的设备、检验的耗材以及支援规模化生产的强大服务模式的需求。同时，欧洲、中东和非洲呈现出一种多元化的格局，成熟的研究中心与新兴的临床市场并存。在这里，监管的细微差别和报销途径决定了采用时间表，与当地经销商的伙伴关係通常决定了市场进入和支援品质。

亚太地区产能扩张迅猛，国内创新不断加强，国内供应商数量不断成长，持续成为重要的製造能力中心，用户群也迅速扩张。这种区域性成长往往会加剧价格竞争，并刺激区域服务网络的发展。在所有地区，标准的统一性、训练有素的人才储备以及物流基础设施将影响新型分离技术从试点应用到常规部署的速度，因此区域策略将成为商业和营运规划的核心。

竞争定位、平台整合和不断发展的服务模式如何塑造供应商策略并在细胞分离领域创造差异化的价值提案

供应商之间的竞争日益由产品创新、平台整合和商业合作模式的结合所定义。领先的公司正在扩展其产品组合，将仪器与专有耗材和软体分析相结合，以确保长期经常性收益并提升用户体验。此外，仪器供应商和软体开发商之间的策略联盟加速了端到端工作流程，缩短了从样本到洞察的路径。同时，专业供应商继续透过利基产品实现差异化，例如用于干细胞的温和分离技术或用于肿瘤学应用的高速分选器，为重点创新和广泛的平台整合腾出空间。

对于需要可预测正常运作的临床和大规模製造客户来说，维护合约、远距离诊断和培训计画已成为特别重要的价值因素。併购活动反映出一个市场，在这个市场中，专业知识的规模和深度都至关重要，同时对特定应用研发的选择性投资也至关重要。对于决策者而言，能够证明工作流程检验、法规支援以及与下游检测和资料生态系统的互通性正在成为竞争优势。

领导者应采取指南，增强供应弹性，加速采用检验的技术，并整合资料互通性，以实现可扩展的细胞分离工作流程

产业领导者应采用投资组合方法，在短期营运弹性和长期创新投资之间取得平衡。首先，优先考虑多方采购和库存缓衝，以缓解供应链衝击和关税造成的成本波动，同时协商合约条款，确保批次可追溯性和品质保证。其次，投资可互通的数据平台和检验的分析方法，以实现跨供应商集成，并加速将分离结果转化为下游检测和製造流程。这些投资可以减少协作研究过程中的摩擦，并支持分散式团队获得可重复的结果。

同时，各机构应评估在需要温和处理和单细胞分辨率的工作流程中试行自动化和微流体解决方案的机会，并透过分阶段的检验计划降低采用风险。与供应商建立密切的伙伴关係，共同开发特定应用的套件和服务协议，可以缩短验证週期并降低整体拥有成本。最后，致力于人才培养，透过有针对性的培训计划来提高操作员的熟练程度和仪器的运作，并将监管准备计划纳入早期开发里程碑，以简化临床和商业化路径。

一种透明的、多来源的调查方法，结合相关人员访谈、技术文献综述和交叉检验，以产生可操作且可辩护的见解

本分析背后的调查方法结合了多元化的依证，以确保得出稳健且可复製的结论。主要研究包括对实验室主任、采购专员、设备工程师和临床营运负责人的结构化访谈，以了解研究和临床环境中的营运现状和应用驱动因素。次要研究包括官方监管文件、同行评审文献和製造商技术规范，以检验性能声明并了解监管限制和检验要求。整合这些资讯来源，以确定主题趋势、技术曲折点以及最终用户使用的实际决策标准。

透过跨资料类型交叉检验、将定性见解与已发表的技术基准进行三角检验以及敏感性检查，确保分析的严谨性，从而确保在不同操作假设下结论的一致性。我们强调假设的透明度，并记录了需要仔细解读的稀缺数据领域，例如早期微流体平台和专有试剂配方。本调查方法支持实践指南，同时认识到现有资讯的局限性和技术进步的动态性。

趋势摘要强调互通性、供应弹性和劳动力准备度是提供可扩展和可重复的细胞分离结果的关键因素

摘要，细胞分离和离析技术在技术改进、服务导向的商业模式以及区域差异化应用路径的共同作用下不断发展。最重要的趋势包括向资料整合工作流程的转变、针对敏感细胞类型的更温和的分离方法的成熟，以及在关税和物流压力下，弹性供应链的重要性日益提升。最终用户现在不仅关注仪器性能，还关註生命週期服务、软体互通性和法规遵从性。

展望未来，重视互通性、供应商协作和员工能力的组织将最有能力将其分离能力转化为下游研究和临床价值。虽然技术选择会因细胞类型和应用而异，但策略重点很明确：协调投资，以实现可重复、可扩展的工作流程，使其能够顺利融入分析和製造生态系统，从而加速科学和治疗成果的实现。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 基于微流体的无标定细胞分离平台集成，用于高通量分选
  • 以微珠为基础磁珠的自动免疫磁分离系统在临床细胞治疗生产的应用
  • 新兴的无标定声学和介电泳技术，用于大规模、温和的活细胞分选
  • 微流体分离与单细胞多组体学工作流程结合，用于精准医学研究
  • 将人工智慧应用于基于影像的细胞分选以提高特异性和吞吐量

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 细胞分离/细胞分离市场（依产品）

  • 耗材
    • 一次性的
    • 试剂
  • 装置
  • 套件
  • 软体和服务
    • 数据分析软体
    • 维护服务

9. 细胞分离/细胞分离市场（依技术）

  • 离心
  • 滤
  • 流式细胞技术
    • 分析细胞计数法
    • 分选流式细胞仪
  • 磁珠
    • 大珠
    • 奈米珠
  • 微流体

10. 细胞分离/细胞分离市场（依细胞类型）

  • B细胞
  • 癌细胞
  • 树突状细胞
  • 干细胞
  • T细胞

第 11 章。细胞分离/细胞分离市场（依应用）

  • 细胞疗法
  • 免疫学
  • 感染疾病
  • 肿瘤学
  • 产前检查
  • 干细胞研究

第 12 章：细胞分离/细胞分离市场（依最终用户）

  • 学术研究机构
  • 生物技术和製药公司
  • 合约研究组织
  • 医院和诊所

13. 细胞分离/细胞分离市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章。细胞分离/细胞分离市场（按组）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 细胞分离/细胞分离市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Thermo Fisher Scientific Inc
    • Becton, Dickinson and Company
    • Danaher Corporation
    • Beckman Coulter, Inc
    • Bio-Rad Laboratories, Inc
    • Agilent Technologies, Inc
    • Merck KGaA
    • Lonza Group AG
    • Sartorius AG
    • Terumo Corporation
Product Code: MRR-034230D3E62F

The Cell Isolation/Cell Separation Market is projected to grow by USD 39.25 billion at a CAGR of 14.88% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 12.93 billion
Estimated Year [2025] USD 14.84 billion
Forecast Year [2032] USD 39.25 billion
CAGR (%) 14.88%

A concise orientation to core cell isolation technologies, evolving end-user priorities, and the strategic considerations shaping translational research and clinical pipelines

Cell isolation and separation technologies underpin a broad spectrum of life sciences research and clinical applications, from basic immunology studies to advanced cell therapy manufacturing. Advances in instrumentation and reagents have progressively lowered barriers to precise single-cell and bulk-cell processing, enabling more reproducible workflows and accelerating translational pathways. As academic groups, biotech innovators, and clinical laboratories increasingly demand scalable and automation-friendly solutions, the landscape of available tools has diversified to meet divergent throughput, purity, and viability requirements.

In consequence, stakeholders must evaluate technologies not only for analytical performance but also for their integration into data pipelines, regulatory compliance frameworks, and downstream processing. The convergence of microfluidics, magnetic separation, and high-resolution flow cytometry with cloud-enabled data analysis is reshaping how teams design experiments and scale processes. This introduction frames the subsequent sections by highlighting core technological drivers, evolving end-user needs, and the strategic considerations that inform procurement and development choices across research, clinical, and commercial settings.

How technological convergence, automation, and data-enabled workflows are redefining cell isolation practices and reshaping supplier and end-user dynamics

The landscape of cell isolation has experienced transformative shifts driven by both technology convergence and evolving application demands. Initially, improvements centered on enhancing cell purity and recovery through refined reagents and more sensitive cytometric instrumentation. More recently, the most consequential changes have arisen from the integration of automated sample handling and computational analysis, which together enable reproducible processing at scales previously unattainable for many laboratories.

Moreover, the development of gentle separation modalities - including nanomaterial-enhanced magnetic beads and microfluidic platforms designed to preserve cell phenotype - has opened new possibilities for delicate cell types such as stem cells and primary immune populations. As a result, workflows that once required specialist expertise are becoming accessible to a broader set of end users. Simultaneously, competitive dynamics have pushed providers to bundle consumables with service models and software, creating ecosystems that accelerate adoption but also raise considerations around vendor lock-in and data interoperability. These shifts are leading laboratories and companies to reassess procurement criteria with greater emphasis on operational continuity, data integrity, and the ability to translate isolated-cell outputs into downstream assays and therapies.

Assessing how 2025 United States tariff adjustments are altering procurement, supply chain strategies, and manufacturer sourcing decisions across the cell separation ecosystem

Recent tariff changes announced by the United States for 2025 have introduced new variables that affect procurement strategies, supply chain resiliency, and cross-border collaboration in the cell isolation domain. Tariff activity has a cascading effect: increased import levies on instruments and specialized reagents heighten landed costs, which in turn requires laboratory procurement teams to re-evaluate purchase timing, vendor selection, and inventory strategies. Consequently, organizations are balancing short-term cost pressures with longer-term operational risks associated with substituting suppliers or switching to alternate technologies that may not yet be fully validated for their workflows.

In addition to price implications, tariffs influence supplier behavior and investment decisions. Some manufacturers respond by regionalizing production, diversifying component sourcing, or adjusting their distribution models to mitigate exposure. These adjustments can create transitional friction for customers who rely on consistent reagent lots and instrument part compatibility. Regulatory and customs delays, amplified by changed tariff classifications, also extend lead times and complicate just-in-time inventory approaches. To navigate this environment, organizations are increasingly prioritizing multi-sourcing strategies and establishing closer collaborations with vendors to secure supply continuity and maintain experimental reproducibility despite evolving trade policies.

Comprehensive segmentation-driven insights linking product categories, enabling technologies, cell types, and end-user priorities to inform procurement and development decisions

Understanding market dynamics requires clarity across multiple segmentation axes and the practical implications of each category for buyers and developers. From a product perspective, stakeholders differentiate among consumables, instruments, kits, and software and services; within consumables, disposables and reagents determine per-run economics and assay consistency, while data analysis software and maintenance services shape lifecycle value and uptime. Transitioning from product to technology, techniques such as centrifugation and filtration remain foundational for bulk separations, whereas flow cytometry, magnetic beads, and microfluidics support higher-resolution and targeted applications; the flow cytometry category itself divides between analytical cytometry and sorting cytometry, and magnetic bead technologies vary by scale from macro beads to nano beads, each offering trade-offs in binding kinetics and cell recovery.

Equally important is cell type segmentation, which directs technology choice: B cells, T cells, dendritic cells, stem cells, and cancer cells each impose distinct requirements for viability preservation, purity thresholds, and downstream compatibility. Application segmentation further refines priorities because cell therapy and stem cell research demand gentle, GMP-aligned workflows, while infectious disease and prenatal testing place premium value on speed, diagnostic sensitivity, and regulatory traceability. Finally, end-user segmentation highlights operational diversity: academic and research institutes prioritize experimental flexibility and cost-efficiency; biotech and pharma companies focus on scalability and regulatory alignment; contract research organizations emphasize throughput, reproducibility, and client reporting; and hospitals and clinics require clinical-grade reliability and integration with patient-care pathways. Together, these segmentation lenses create a nuanced map of requirements that innovators and purchasers must navigate when evaluating technologies and partnerships.

Regional dynamics and infrastructure considerations that influence the adoption pace, supplier strategies, and regulatory alignment across the Americas, EMEA, and Asia-Pacific

Regional dynamics impart distinct imperatives for technology adoption, supplier strategies, and regulatory alignment. In the Americas, investment in translational research and the growth of cell therapy manufacturing hubs drive demand for GMP-compatible instruments, validated consumables, and robust service models that support scale-up. Meanwhile, Europe, Middle East & Africa present a heterogeneous picture in which well-established research centers coexist with emerging clinical markets; here, regulatory nuance and reimbursement pathways shape adoption timelines, and partnerships with local distributors often determine market access and support quality.

Asia-Pacific continues to be a major locus of manufacturing capability and a rapidly expanding user base, characterized by aggressive capacity building, increasing domestic innovation, and growing domestic suppliers. This regional push frequently accelerates price competition and stimulates the development of localized service networks. Across all regions, harmonization of standards, the availability of trained personnel, and logistics infrastructure affect how quickly new separation technologies move from pilot use to routine deployment, making regional strategies central to commercial and operational planning.

How competitive positioning, platform integration, and evolving service models are shaping supplier strategies and creating differentiated value propositions in cell separation

Competitive activity among suppliers is increasingly defined by a mix of product innovation, platform integration, and commercial partnership models. Leading firms are expanding portfolios to couple instruments with proprietary consumables and software analytics to lock in long-term recurring revenue and improve user experience. Additionally, strategic alliances between instrument vendors and software developers accelerate end-to-end workflows that shorten the path from sample to insight. On the other hand, specialist providers continue to differentiate through niche offerings such as gentle isolation technologies for stem cells or high-speed sorters for oncology applications, preserving space for focused innovation alongside broader platform consolidation.

Service propositions are also evolving: maintenance contracts, remote diagnostics, and training programs have become essential elements of value, particularly for clinical and large-scale manufacturing customers who require predictable uptime. Mergers and acquisition activity, along with selective investments in application-specific R&D, reflect a marketplace where scale and depth of expertise both matter. For decision-makers, competitive positioning increasingly hinges on the ability to demonstrate validated workflows, regulatory support, and proven interoperability with downstream assays and data ecosystems.

Actionable pathways for leaders to strengthen supply resilience, accelerate validated technology adoption, and embed data interoperability for scalable cell separation workflows

Industry leaders should adopt a portfolio approach that balances near-term operational resilience with long-term innovation investments. First, prioritize multi-sourcing and inventory buffering to mitigate supply chain shocks and tariff-driven cost volatility, while negotiating contractual terms that preserve lot traceability and quality assurance. Second, invest in interoperable data platforms and validated analytics to enable cross-vendor integration and accelerate the translation of isolation outputs into downstream assays and manufacturing steps. These investments reduce friction during collaborations and support reproducible outcomes across distributed teams.

Concurrently, organizations should evaluate opportunities to pilot automation and microfluidic solutions for workflows that demand gentle handling or single-cell resolution, using staged validation plans to de-risk adoption. Building closer partnerships with suppliers to co-develop application-specific kits and service agreements can shorten validation cycles and improve total cost of ownership. Finally, commit to workforce development through targeted training programs that enhance operator proficiency and instrument uptime, and incorporate regulatory-readiness planning into early development milestones to streamline clinical translation and commercialization pathways.

A transparent, multi-source research methodology blending stakeholder interviews, technical literature review, and cross-validation to produce actionable and defensible insights

The research methodology underpinning this analysis combined a multi-pronged evidence base to ensure robust, reproducible conclusions. Primary inputs included structured interviews with laboratory directors, procurement specialists, instrument engineers, and clinical operations leaders to capture operational realities and adoption drivers across research and clinical settings. Secondary inputs encompassed public regulatory documents, peer-reviewed literature, and manufacturer technical specifications to validate performance claims and to understand regulatory constraints and validation requirements. These sources were synthesized to identify thematic trends, technology inflection points, and practical decision criteria used by end users.

Analytical rigor was maintained through cross-validation across data types, triangulation of qualitative insights with published technical benchmarks, and sensitivity checks to ensure conclusions remained consistent under varying operational assumptions. Emphasis was placed on transparency in assumptions and on documenting areas where data scarcity necessitated cautious interpretation, such as nascent microfluidic platforms or proprietary reagent formulations. This methodological approach supports actionable guidance while acknowledging the limits of available information and the dynamic nature of technological advancement.

Concluding synthesis of trends emphasizing interoperability, supply resilience, and workforce readiness as the critical enablers of scalable and reproducible cell isolation outcomes

In summary, cell isolation and separation continue to evolve through a combination of technological refinement, service-oriented commercial models, and regionally distinct adoption pathways. The most consequential trends are the shift toward data-integrated workflows, the maturation of gentle separation modalities for sensitive cell types, and the increasing importance of resilient supply chains in the face of tariff and logistics pressures. These forces collectively reshape procurement criteria, where end users now place comparable emphasis on lifecycle service, software interoperability, and regulatory compatibility as they do on raw instrument performance.

Looking ahead, organizations that prioritize interoperability, supplier collaboration, and workforce capability will be best positioned to translate isolation capabilities into downstream research and clinical value. While technology selection will remain contingent on cell type and application, the broader strategic emphasis is clear: align investments to enable reproducible, scalable workflows that integrate smoothly into analytical and manufacturing ecosystems, thereby accelerating scientific and therapeutic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of microfluidic-based label-free cell separation platforms for high-throughput sorting
  • 5.2. Adoption of automated magnetic bead-based immunomagnetic separation systems for clinical cell therapy manufacturing
  • 5.3. Emergence of label-free acoustic and dielectrophoretic techniques for gentle viable cell sorting at scale
  • 5.4. Integration of single-cell multiomics workflows with microfluidic isolation for precision medicine research
  • 5.5. Application of artificial intelligence-driven image-based cell sorting to enhance specificity and throughput

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cell Isolation/Cell Separation Market, by Product

  • 8.1. Consumables
    • 8.1.1. Disposables
    • 8.1.2. Reagents
  • 8.2. Instruments
  • 8.3. Kits
  • 8.4. Software And Services
    • 8.4.1. Data Analysis Software
    • 8.4.2. Maintenance Services

9. Cell Isolation/Cell Separation Market, by Technology

  • 9.1. Centrifugation
  • 9.2. Filtration
  • 9.3. Flow Cytometry
    • 9.3.1. Analytical Cytometry
    • 9.3.2. Sorting Cytometry
  • 9.4. Magnetic Beads
    • 9.4.1. Macro Beads
    • 9.4.2. Nano Beads
  • 9.5. Microfluidics

10. Cell Isolation/Cell Separation Market, by Cell Type

  • 10.1. B Cells
  • 10.2. Cancer Cells
  • 10.3. Dendritic Cells
  • 10.4. Stem Cells
  • 10.5. T Cells

11. Cell Isolation/Cell Separation Market, by Application

  • 11.1. Cell Therapy
  • 11.2. Immunology
  • 11.3. Infectious Diseases
  • 11.4. Oncology
  • 11.5. Prenatal Testing
  • 11.6. Stem Cell Research

12. Cell Isolation/Cell Separation Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Biotech And Pharma Companies
  • 12.3. Contract Research Organizations
  • 12.4. Hospitals And Clinics

13. Cell Isolation/Cell Separation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cell Isolation/Cell Separation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cell Isolation/Cell Separation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc
    • 16.3.2. Becton, Dickinson and Company
    • 16.3.3. Danaher Corporation
    • 16.3.4. Beckman Coulter, Inc
    • 16.3.5. Bio-Rad Laboratories, Inc
    • 16.3.6. Agilent Technologies, Inc
    • 16.3.7. Merck KGaA
    • 16.3.8. Lonza Group AG
    • 16.3.9. Sartorius AG
    • 16.3.10. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. CELL ISOLATION/CELL SEPARATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. CELL ISOLATION/CELL SEPARATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CELL ISOLATION/CELL SEPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2024 (USD MILLION)